Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy

Radiotherapy can be safely delivered during the coronavirus disease 2019 (COVID-19) pandemic, often through use of hypofractionated regimens, which minimize the number of visits to treatment centres while also avoiding potentially detrimental delays in the delivery of cancer care.

Detalles Bibliográficos
Autores principales: Nagar, Himanshu, Formenti, Silvia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184542/
https://www.ncbi.nlm.nih.gov/pubmed/32341524
http://dx.doi.org/10.1038/s41571-020-0375-1
Descripción
Sumario:Radiotherapy can be safely delivered during the coronavirus disease 2019 (COVID-19) pandemic, often through use of hypofractionated regimens, which minimize the number of visits to treatment centres while also avoiding potentially detrimental delays in the delivery of cancer care.

Ejemplares similares